# Norepinephrine or phenylephrine for the prevention of post-spinal hypotension after caesarean section: A double-blinded, randomized, controlled study of fetal heart rate and fetal cardiac output

- **DOI:** [10.1016/j.jclinane.2024.111533](https://doi.org/10.1016/j.jclinane.2024.111533)
- **Rating:** Sound (3.4 out of 5)
- **Verdict:** A blinded vasopressor trial adds direct fetal-circulation evidence in elective caesareans, but its null comparisons do not establish equivalence or absence of harm.
- **Framework version:** v5.10
- **Pipeline version:** v0.4
- **Evaluation date:** 2026-11-02
- **Evaluation page:** https://www.nabu.science/paper/10.1016%2Fj.jclinane.2024.111533

## Key claims

1. Prophylactic infusion of comparable doses of phenylephrine or norepinephrine has similar effects on fetal heart rate and cardiac output changes after spinal anesthesia.
   - Support: Tentative
   - Type: Primary finding
   - Basis: superiority testing without equivalence margins cannot establish similarity despite no detected between-group differences
   - Location: Abstract; Conclusions; Highlights
2. there was a statistically significant decrease in fetal cardiac output in both groups.
   - Support: Tentative
   - Type: Secondary
   - Basis: within-group inference rests on single Doppler measurements and an unspecified paired testing approach
   - Location: Results, paragraph 3; Table 3
3. Neither phenylephrine nor norepinephrine has meaningful detrimental effects on fetal circulation or neonatal outcomes.
   - Support: Tentative
   - Type: Secondary
   - Basis: short-term active-comparator testing without an unexposed control or powered clinical safety endpoints cannot exclude meaningful harm
   - Location: Abstract; Conclusions; Highlights

## Strengths

- **Randomised allocation with extensive personnel masking** An independent team member generated allocation, and an uninvolved assistant prepared study drugs. Patients, anaesthetists, the sonographer, and data collectors were blinded.
  - Dimension: methodological rigour
  - Location: Methods 2.2; Table 1
- **Direct measurements extend fetal circulation evidence** Serial Doppler measurements address fetal heart rate and cardiac output directly, extending comparisons previously centred on maternal haemodynamics and neonatal blood gases.
  - Dimension: contribution
  - Location: Introduction; Methods 2.4; Table 3
- **Systematic maternal and neonatal outcome reporting** The trial monitored maternal adverse events alongside fetal perfusion measures, umbilical blood gases, Apgar scores, and neonatal admission.
  - Dimension: methodological rigour
  - Location: Methods 2.4; Tables 2–4

## Limitations

- **Null comparisons cannot establish clinical equivalence** The power calculation draws on maternal cardiac-output data rather than fetal-outcome variance. No equivalence margin or between-group confidence intervals establish that clinically meaningful differences are excluded.
  - Dimension: methodological rigour
  - Location: Methods 2.5; Table 3
- **Post-randomisation exclusions lack analytical sensitivity checks** Ten norepinephrine and seven phenylephrine participants were excluded after randomisation. Analysis of the remaining 90 and 93 participants lacks an intention-to-treat or sensitivity analysis.
  - Dimension: methodological rigour
  - Location: Results, participant flow paragraph
- **Safety wording exceeds the comparative design** The conclusion of no meaningful fetal or neonatal detriment goes beyond a low-risk, short-term comparison without an unexposed control or adequately powered clinical safety outcomes.
  - Dimension: reporting
  - Location: Abstract, Conclusions; Methods 2.1 and 2.5; Discussion, concluding paragraph

## Reliability checks

Caveats (4 of 4 checks).

- **Results check:** Noted
  - there was a statistically significant decrease in fetal cardiac output in both groups: "norepinephrine group (mean difference 0.02 L/min; 95% CI, 0–0.04 L/min; P = 0.03)" (Abstract, Main results). The printed confidence interval has a zero lower limit alongside P = 0.03, but rounding could conceal a positive lower limit, so unrounded agreement cannot be determined. → Effect on result unclear
  - Minor reporting notes (1):
    - Descriptive: "The incidence of maternal bradycardia in Group PE was significantly greater than that in Group NE (P = 0.0)." (Results, paragraph 2) vs "Bradycardia | 1 (1.1%) | 8 (8.6%) | 0.04" (Table 2). Comparing the same maternal-bradycardia comparison across the Results narrative and Table 2 gives P = 0.0 versus P = 0.04. → Conclusion holds
- **Reporting and transparency:** Noted. The Methods contain a circular definition of cardiac output, without evidence that the numerical analysis used that definition. Ethics approval, prospective registration, and a conflict-of-interest declaration are reported.
  - Conflict of interest: declared · Ethics approval: declared · Preregistration: declared
- **Reference integrity:** Clean. 21 of 21 checkable references verified
  - 21 references in manuscript
  - References not verified automatically are resolved manually within 24 hours.

## Post-publication record

- **Status:** Clean
- **Summary:** No retraction or expression of concern found in Crossref (includes Retraction Watch).
- **Last checked:** 2026-11-02
